Abstract
Background Pulmonary sarcomatoid carcinoma (PSC) is rare with a poor outcome and is resistant to conventional cytotoxic chemotherapy. The efficacy and......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
